GENE ONLINE|News &
Opinion
Blog

Editors' Picks
Moving Beyond COVID With mRNA Technology
2023-01-18
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
2023 Trend Forecast: Transforming Healthcare with Real-world Data and Personalized Medicine
2023-01-05
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
Moving Past Animal Models with Better Data for Drug Discovery
2022-11-23Partner
BioFuture NYC 2022: Using Technology to Prepare for an Aging Population
2022-11-22
Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates
2022-11-17Partner
Walmart To Settle Opioid Lawsuits with $3.1 Billion, U.S. Government Mulls OTC Naloxone
2022-11-15
Transforming Southern California Biotech Landscape: An Interview With SoCalBio CEO Ahmed Enany
2022-10-18
FDA Drops New Oncology Development Guidelines
2022-10-18
FDA Pushes Biogen’s ALS Drug Approval Date Back Three Months
2022-10-18
Biden’s New Executive Order Directs HHS to Find Ways to Lower Drug Prices
2022-10-16
Ginkgo Bioworks and Merck’s Collaboration Worth Up to $144 million
2022-10-13
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
1 2 3 11
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!